Upstream Bio (UPB) Payables: 2023-2025

Historic Payables for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $4.0 million.

  • Upstream Bio's Payables fell 19.33% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $4.0 million for FY2024, which is 103.07% up from last year.
  • Per Upstream Bio's latest filing, its Payables stood at $4.0 million for Q3 2025, which was up 54.92% from $2.6 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Payables peaked at $4.9 million during Q3 2024, and registered a low of $2.0 million during Q4 2023.
  • Its 3-year average for Payables is $3.7 million, with a median of $4.0 million in 2024.
  • Per our database at Business Quant, Upstream Bio's Payables skyrocketed by 103.07% in 2024 and then declined by 19.33% in 2025.
  • Quarterly analysis of 3 years shows Upstream Bio's Payables stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then decreased by 19.33% to $4.0 million in 2025.
  • Its Payables was $4.0 million in Q3 2025, compared to $2.6 million in Q2 2025 and $4.7 million in Q1 2025.